Literature DB >> 4033421

Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes.

H Ishida, Y Seino, S Matsukura, M Ikeda, M Yawata, G Yamashita, S Ishizuka, H Imura.   

Abstract

The degree of diabetic osteopenia and serum vitamin D metabolite levels were measured in 168 type 2 (noninsulin-dependent) diabetic patients. Based on six indices obtained by microdensitometry, we found the bone mass in 26.2% of diabetic patients to be clearly decreased and in 11.9% to be severely decreased. Our direct method of analysis of bone mass shows that diabetic osteopenia differs from typical osteoporosis in character. In addition, serum 24,25-dihydroxyvitamin D was significantly decreased (P less than 0.01), but 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D were similar to those of controls.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4033421     DOI： 10.1016/0026-0495(85)90101-5

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


  18 in total

1.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

2.  Prospective study of ultraviolet radiation exposure and mortality risk in the United States.

Authors:  Shih-Wen Lin; David C Wheeler; Yikyung Park; Michael Spriggs; Albert R Hollenbeck; D Michal Freedman; Christian C Abnet
Journal:  Am J Epidemiol       Date:  2013-07-17       Impact factor: 4.897

3.  Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Authors:  T Shibata; S Takeuchi; S Yokota; K Kakimoto; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Intestinal calcium absorption during hyperinsulinemic euglycemic glucose clamp in healthy humans.

Authors:  G Rümenapf; J Schmidtler; P O Schwille
Journal:  Calcif Tissue Int       Date:  1990-02       Impact factor: 4.333

5.  Decreased response of osteoblasts obtained from aged Cohen diabetic sensitive rats to sex steroid hormones and 1,25OH2D3 in culture.

Authors:  Asher Ornoy; Perchia Yaffe; Sarah W Zangen; Nathan Patlas; Zvi Schwartz
Journal:  Odontology       Date:  2006-09       Impact factor: 2.634

6.  The role of vitamin D in the metabolic homeostasis of diabetic bone.

Authors:  Kathryn M Thrailkill; John L Fowlkes
Journal:  Clin Rev Bone Miner Metab       Date:  2013-03-01

7.  Risk of fractures and bone abnormalities in postmenopausal women with type 2 diabetes mellitus.

Authors:  Maria Giovanna Filippella; Antongiulio Faggiano; Alberto Falchetti; Annamaria Colao; Carlo Rosa; Carlo Poti; Corrado Musso; Giulio Doveri; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-05

Review 8.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.

Authors:  Anastassios G Pittas; Joseph Lau; Frank B Hu; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

9.  Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men.

Authors:  Tracie C Collins; Susan K Ewing; Susan J Diem; Brent C Taylor; Eric S Orwoll; Steven R Cummings; Elsa S Strotmeyer; Kristine E Ensrud
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

10.  Increasing serum osteocalcin after glycemic control in diabetic men.

Authors:  S Sayinalp; O Gedik; Z Koray
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.